Prostate specific antigen (PSA) testing
Basky G, Belon R, Boutin B, McGowan V, Nisbet B, Tonita J
Record ID 31998008945
English
Authors' objectives:
This report reviews the current medical literature and Saskatchewan data on PSA testing.
Authors' recommendations:
Based on its review of the evidence, the panel developed a clinical practice guideline which HSURC sent to family physicians and urologists in 1995. The guideline recommends the test not be used to screen men without signs or symptoms of prostate cancer.
The panel recommends that the PSA test be used selectively in men who have symptoms of prostate problems and/or an abnormal finding on a digital rectal exam (DRE) and for whom treatment would be appropriate (under age 70/life expectancy > 10 years).
Authors' methods:
Overview
Details
Project Status:
Completed
URL for project:
http://www.hqc.sk.ca/resources.html
Year Published:
1995
English language abstract:
An English language summary is available
Publication Type:
Not Assigned
Country:
Canada
MeSH Terms
- Mass Screening
- Prostate-Specific Antigen
- Prostatic Neoplasms
Contact
Organisation Name:
Health Services Utilization and Research Commission
Contact Address:
Health Services Utilization and Research Committee Box 46, 103 Hospital Drive, Saskatoon SK S7N 0W8, Canada Tel: (306) 655-1500, Fax: (306) 655-1462
Contact Name:
nisbetb@sdh.sk.ac. This organisation is now closed. Please see the Health Quality Council (HQC) website for further information at: http://www.hqc.sk.ca/.
Contact Email:
nisbetb@sdh.sk.ac. This organisation is now closed. Please see the Health Quality Council (HQC) website for further information at: http://www.hqc.sk.ca/.
Copyright:
Health Services Utilization and Research Commission
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.